Growth Metrics

LeonaBio (LONA) Leases (2020 - 2026)

LeonaBio (LONA) reported Leases of $461000.0 for Q1 2026, down 37.95% year-over-year from $743000.0 in Q1 2025, and down 13.83% on a QoQ basis from $535000.0 in Q4 2025.

LeonaBio (LONA) has 7 years of Leases data on file, last reported at $461000.0 in Q1 2026.

  • Quarterly Leases fell 37.95% year-over-year to $461000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $461000.0 (down 37.95% YoY) and the FY2025 annual result came in at $535000.0, down 33.79% from the prior year.
  • Leases declined to $461000.0 in Q1 2026 per LONA's latest filing, from $535000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.6 million in Q2 2022 and bottomed at $461000.0 in Q1 2026.
  • The 5-year median for Leases is $992000.0 (2024), against an average of $1.0 million.
  • The widest annual swing landed in 2022, when Leases gained 6.53%; it then plunged 37.95% in 2026.
  • Tracing LONA's Leases over 5 years: stood at $1.3 million in 2022, then fell by 16.94% to $1.0 million in 2023, then declined by 22.97% to $808000.0 in 2024, then plunged by 33.79% to $535000.0 in 2025, then declined by 13.83% to $461000.0 in 2026.
  • Per Business Quant, the three latest LONA Leases figures stand at $461000.0 (Q1 2026), $535000.0 (Q4 2025), and $607000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 61,822.50
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 189.30 Mn
10 LeonaBio 181.52 Mn 113.84 Mn - 461,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 461,000.00
Dec 31, 2025 535,000.00
Sep 30, 2025 607,000.00
Jun 30, 2025 676,000.00
Mar 31, 2025 743,000.00
Dec 31, 2024 808,000.00
Sep 30, 2024 871,000.00
Jun 30, 2024 933,000.00
Mar 31, 2024 992,000.00
Dec 31, 2023 1.05 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.21 Mn
Dec 31, 2022 1.26 Mn
Sep 30, 2022 1.59 Mn
Jun 30, 2022 1.65 Mn
Mar 31, 2022 1.42 Mn
Dec 31, 2021 1.46 Mn
Sep 30, 2021 1.50 Mn
Jun 30, 2021 1.55 Mn
Mar 31, 2021 1.43 Mn
Dec 31, 2020 936,000.00
Sep 30, 2020 959,000.00